WHO ICTRP trial
Efficacy and safety of oral sirolimus in vascular malformation
CTRI/2025/12/098353 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2025/12/098353 |
|---|---|
| Public title | Efficacy and safety of oral sirolimus in vascular malformation |
| Scientific title | Efficacy and safety of oral sirolimus in vascular malformation: A prospective pilot assessor-blinded interventional study. - nil |
| Primary sponsor | nil |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere Health Condition 2: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere |
| Interventions | Intervention1: oral sirolimus: oral sirolimus 0.8ng/m2 over 1 year Control Intervention1: nil: nil |
| Registration date | Mar 12, 2025 |
| Target size | 30 |
| Secondary IDs | nil |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: